Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (6760)	6/10/1999 11:10:00 PM
From: sim1	Respond to of 9719

David - from a Yahoo search. Company Press Release SOURCE: Chicago Biotech Network Chicago Biotech Network Hosts Pentech Pharmaceuticals CHICAGO, June 3 /PRNewswire/ -- The Chicago Biotech Network will feature a presentation by Al Hummel, President of Pentech Pharmaceuticals, Inc., on Tuesday, June 15, 1999, from 5:00 p.m. to 8:00 p.m. at the University of Illinois at Chicago, Molecular Biology Research Building, 900 South Ashland Avenue, Chicago. Mr. Hummel will describe how Pentech managed growth through the early stages of development and landed a multi-million dollar deal with Abbott's TAP Pharmaceuticals venture for the company's apomorphine product. Pentech, a pharmaceutical company based in Wheeling, Illinois, has basic technological strengths in drug delivery and male sexual dysfunction. Guest panelists will comment on Pentech's experiences and discuss key marketing and regulatory strategies important to all biotech companies. Panel members are: Alexander B. Johns, President, BioStrategies Group, Inc. of Chicago, specializing in marketing services such as product strategy, segmentation, and competitor analysis, and Dr. Esam Z. Dajani, President, IDDC Corporation of Long Grove, Illinois, focused on successful registration of drugs, biological and medical devices. CBN Officer, Michael J. Hogg, Partner, BusinessCounsel of Chicago, will serve as Program Moderator. The Chicago Biotech Network is a trade association dedicated to promoting the biotech industry around Chicago and across Northern Illinois. Members range from biotech start-ups to multinational corporations, and world-class universities. The June 15 seminar is Part Three in a series entitled, ''Financing Biotech from Start-Up to Buy-Out,'' presented by CBN in partnership with the Office of the Vice Chancellor of Research for the University of Illinois at Chicago and sponsored by The Illinois Department of Agriculture. Future programs include a seminar on financing biotech companies in advanced development stages and the CBN Illinois Biotech Conference and Expo. The seminar registration fee for June 15 is $10 for CBN members and $20 for nonmembers. To register, call the Chicago Biotech Network at 773-878-4421 or send e-mail to mdbchgo@aol.com. SOURCE: Chicago Biotech Network sdsnmr.com biz.yahoo.com